Results 111 to 120 of about 318,673 (186)

Blood Transfusions: Are They Life Saving or Transfusing Infections? [PDF]

, 2011
Introduction: There is a risk of 1 - 2 per 1000 recipients receiving contaminated blood with viral, bacterial and parasitic agents.TTI’S are the most commonly encountered complications in transfusion medicine.
Amrutha Kumari, B, Deepa, S, Venkatesha, D   +2 more
core   +1 more source

HIV Antibody [PDF]

, 2020
openaire   +1 more source

Absence of Chronic Human Immunodeficiency Virus Infection without Seroconversion in Intravenous Drug Users: A Prospective and Retrospective Study [PDF]

, 2017
It has been reported that human immunodeficiency virus type 1 (HIV-1) infection may exist in persons without specific antibodies for years. To measure the frequency of a silent carrier state, a study was conducted in a cohort of 124 intravenous drug ...
Chamot, Eric, Deglon, Jean-Jacques, Hirschel, Bernard, Perrin, Luc Henri, Yerly, Sabine   +4 more
core  

Plant-based production of highly potent anti-HIV antibodies with engineered posttranslational modifications. [PDF]

Sci Rep, 2020
Singh AA, Pooe O, Kwezi L, Lotter-Stark T, Stoychev SH, Alexandra K, Gerber I, Bhiman JN, Vorster J, Pauly M, Zeitlin L, Whaley K, Mach L, Steinkellner H, Morris L, Tsekoa TL, Chikwamba R.   +16 more
europepmc   +1 more source

HIV Antibody Measurement [PDF]

, 2020
openaire   +1 more source

Defining criteria for broadly neutralizing HIV antibodies. [PDF]

Front Immunol
David-Fung ES, Belobrajdic KA, Macke JP, Quackenbush CR, Ganguly K, Mamrosh JL.   +5 more
europepmc   +1 more source

Heterologous combinations of VSV-GP and native-like trimers elicit autologous Tier 2 HIV antibodies in rabbits. [PDF]

NPJ Vaccines
Radvan F, Hauser A, Lin LY, Wilmschen-Tober S, Schaber M, Bermejo-Jambrina M, Agbabiaka TO, Peterhoff D, Riepler L, Mendrzyk N, Beierfuß A, Speth C, Moog C, von Laer D, Wagner R, Kimpel J.   +15 more
europepmc   +1 more source

Transient rapamycin treatment avoids unwanted host immune responses toward AAV-delivered anti-HIV antibodies. [PDF]

Nat Commun
Fuchs SP, Mondragon PG, Zabizhin R, Tomer S, Wang L, Cook E, Dudley DM, Weisgrau KL, Furlott J, Coonen J, Alexander E, Xie J, Gao G, Termini JM, Martinez-Navio JM, Zhen A, Desrosiers RC.   +16 more
europepmc   +1 more source

HIV antibodies in babies. [PDF]

BMJ, 1992
Connell JA, Parry JV, Mortimer PP, Burns SM, Klokke A, DE ROSSI, ANITA, GIAQUINTO, CARLO   +6 more
openaire   +2 more sources

Estimation of the breadth of CD4bs targeting HIV antibodies by molecular modeling and machine learning. [PDF]

PLoS Comput Biol, 2019
Conti S, Karplus M.
europepmc   +1 more source